Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Frequently asked questions
What sector does Vera Therapeutics Inc (VERA) operate in?
Vera Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Vera Therapeutics Inc (VERA) current stock price?
As of the latest data, Vera Therapeutics Inc stock price is $28.30, with a previous close of $27.99. Vera Therapeutics Inc gained $0.31 in the last trading session, representing a 1.11% increase.
What is Vera Therapeutics Inc (VERA) current market capitalization?
Vera Therapeutics Inc market cap is approximately 2.04 billion.
What is Vera Therapeutics Inc (VERA) Earnings Per Share (EPS)?
The trailing EPS is -$6.13, and the forward EPS is -$4.64.
What is Vera Therapeutics Inc (VERA) EBITDA?
Vera Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -107.49 million.
Does Vera Therapeutics Inc (VERA) pay dividends?
No. Vera Therapeutics Inc does not pay a dividend.
When is Vera Therapeutics Inc (VERA) next earnings report?
Vera Therapeutics Inc is expected to release its next earnings report on September 30, 2026.
What is Vera Therapeutics Inc (VERA) beta (volatility) score?
Vera Therapeutics Inc has a beta of 0.953, meaning its volatility is roughly in line with the market.
